We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$30.1B
AUM Growth
+$3.48B
Cap. Flow
+$2.15B
Cap. Flow %
7.12%
Top 10 Hldgs %
23.19%
Holding
1,423
New
92
Increased
671
Reduced
310
Closed
81

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$108M
2
CRM icon
Salesforce
CRM
+$101M
3
JNJ icon
Johnson & Johnson
JNJ
+$93.2M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$75.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$66.1M
2
CMS icon
CMS Energy
CMS
+$66.1M
3
AMGN icon
Amgen
AMGN
+$65.7M
4
AEE icon
Ameren
AEE
+$61.6M
5
FIS icon
Fidelity National Information Services
FIS
+$53.8M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Healthcare 15.88%
3 Financials 12.34%
4 Communication Services 9.66%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDR icon
1076
Schneider National
SNDR
$6.12B
$375K ﹤0.01%
+14,909
New +$349K
CDXS icon
1077
Codexis
CDXS
$159M
$372K ﹤0.01%
18,000
OCUL icon
1078
Ocular Therapeutix
OCUL
$2.14B
$361K ﹤0.01%
22,900
ZGNX
1079
DELISTED
Zogenix, Inc.
ZGNX
$356K ﹤0.01%
18,600
KPTI icon
1080
Karyopharm Therapeutics
KPTI
$47.6M
$355K ﹤0.01%
2,413
PTGX icon
1081
Protagonist Therapeutics
PTGX
$9.6B
$354K ﹤0.01%
14,000
TTC icon
1082
Toro Company
TTC
$9.41B
$354K ﹤0.01%
3,405
ZIXI
1083
DELISTED
Zix Corporation
ZIXI
$352K ﹤0.01%
48,800
NRIX icon
1084
Nurix Therapeutics
NRIX
$2.69B
$351K ﹤0.01%
12,400
TVTX icon
1085
Travere Therapeutics
TVTX
$5.68B
$351K ﹤0.01%
14,500
QTTB icon
1086
Q32 Bio
QTTB
$459M
$350K ﹤0.01%
2,139
KEP icon
1087
Korea Electric Power
KEP
$15.8B
$349K ﹤0.01%
34,974
PFPT
1088
DELISTED
Proofpoint, Inc.
PFPT
$345K ﹤0.01%
2,800
CVE icon
1089
Cenovus Energy
CVE
$55B
$344K ﹤0.01%
45,343
+5,466
+14% +$38.4K
NTCT icon
1090
NETSCOUT
NTCT
$2.81B
$342K ﹤0.01%
12,240
QNCX icon
1091
Quince Therapeutics
QNCX
$33.3M
$339K ﹤0.01%
50
AKRO
1092
DELISTED
Akero Therapeutics
AKRO
$338K ﹤0.01%
12,000
SQM icon
1093
Sociedad Química y Minera de Chile
SQM
$20.6B
$337K ﹤0.01%
6,200
ARQT icon
1094
Arcutis Biotherapeutics
ARQT
$3.3B
$334K ﹤0.01%
12,400
RDWR icon
1095
Radware
RDWR
$1.2B
$334K ﹤0.01%
13,150
ICL icon
1096
ICL Group
ICL
$6.89B
$332K ﹤0.01%
56,626
+1,153
+2% +$6.55K
RBA icon
1097
RB Global
RBA
$16.6B
$330K ﹤0.01%
5,682
-84
-1% -$4.93K
NKTX icon
1098
Nkarta
NKTX
$167M
$329K ﹤0.01%
10,500
TVRD
1099
Tvardi Therapeutics
TVRD
$22.1M
$329K ﹤0.01%
450
CEO
1100
DELISTED
CNOOC Limited
CEO
$329K ﹤0.01%
+3,110
New +$340K

Similar funds

DekaBank Deutsche Girozentrale's Q1 2021 Portfolio in Review

As of Q1 2021, DekaBank Deutsche Girozentrale held 1,423 positions worth $30.1B, up 13% from $26.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

DekaBank Deutsche Girozentrale deployed $2.15B of net new capital in Q1 2021, opening 92 new positions and adding to 671 existing holdings. Its largest new stake was Suzano: 450,000 shares worth $5.55M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $66.1M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q1 2021 buy was Suzano: 450,000 shares worth $5.55M.
  • DekaBank Deutsche Girozentrale added most to Intel in Q1 2021, an estimated $108M increase.
  • DekaBank Deutsche Girozentrale's biggest Q1 2021 reduction was NVIDIA, cutting an estimated $66.1M.
  • DekaBank Deutsche Girozentrale fully exited Coherent Inc in Q1 2021, selling an estimated $34.2M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $30.1B portfolio in Q1 2021.
  • DekaBank Deutsche Girozentrale opened 92 new positions and closed 81 in Q1 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 13% quarter-over-quarter to $30.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2021, filed 28 Apr 2021.